CO4810313A1 - Compuestos utiles para tratar infecciones por retrovirus - Google Patents

Compuestos utiles para tratar infecciones por retrovirus

Info

Publication number
CO4810313A1
CO4810313A1 CO95018810A CO95018810A CO4810313A1 CO 4810313 A1 CO4810313 A1 CO 4810313A1 CO 95018810 A CO95018810 A CO 95018810A CO 95018810 A CO95018810 A CO 95018810A CO 4810313 A1 CO4810313 A1 CO 4810313A1
Authority
CO
Colombia
Prior art keywords
phenyl
het
useful compounds
retrovirus infections
cyclopropyl
Prior art date
Application number
CO95018810A
Other languages
English (en)
Spanish (es)
Inventor
Karen Rene Romines
L Bundy Gordon
Theresa M Schwartz
Ruben A Tommasi
Joseph Walter Strohbach
Steven Ronald Turner
Suvit Thaisrivongs
Paul Adrian Aristoff
Paul D Johnson
Joel Irving Skulnick
Louis L Skaletzky
David John Anderson
Joel Morris
Ronald B Gammill
George P Luke
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CO4810313A1 publication Critical patent/CO4810313A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CO95018810A 1994-05-06 1995-05-05 Compuestos utiles para tratar infecciones por retrovirus CO4810313A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23881794A 1994-05-06 1994-05-06
US34936194A 1994-12-02 1994-12-02

Publications (1)

Publication Number Publication Date
CO4810313A1 true CO4810313A1 (es) 1999-06-30

Family

ID=26931995

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95018810A CO4810313A1 (es) 1994-05-06 1995-05-05 Compuestos utiles para tratar infecciones por retrovirus

Country Status (32)

Country Link
US (2) US5852195A (enExample)
EP (1) EP0758327B1 (enExample)
JP (1) JP3883206B2 (enExample)
KR (1) KR100445929B1 (enExample)
CN (2) CN1154642C (enExample)
AT (1) ATE236894T1 (enExample)
AU (2) AU701965B2 (enExample)
BR (1) BR9507615A (enExample)
CA (2) CA2187523C (enExample)
CO (1) CO4810313A1 (enExample)
CZ (1) CZ296515B6 (enExample)
DE (2) DE69530294T2 (enExample)
DK (1) DK0758327T3 (enExample)
ES (1) ES2192201T3 (enExample)
FI (1) FI117387B (enExample)
FR (1) FR05C0047I2 (enExample)
HU (1) HU228057B1 (enExample)
IL (3) IL129871A (enExample)
LU (1) LU91220I2 (enExample)
MX (1) MX9605391A (enExample)
MY (2) MY127701A (enExample)
NL (1) NL300216I2 (enExample)
NO (2) NO315799B1 (enExample)
NZ (1) NZ285510A (enExample)
PE (1) PE23196A1 (enExample)
PL (1) PL190540B1 (enExample)
PT (1) PT758327E (enExample)
RU (1) RU2139284C1 (enExample)
SI (1) SI0758327T1 (enExample)
SK (1) SK284407B6 (enExample)
TW (1) TW504507B (enExample)
WO (1) WO1995030670A2 (enExample)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
ATE249842T1 (de) * 1996-07-03 2003-10-15 Upjohn Co Zielgerichte arzneimittel abgabe für zulphonamide-derivate
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
ES2174462T3 (es) * 1997-07-29 2002-11-01 Upjohn Co Formulacion autoestimulante para compuestos lipofilos.
DK0989851T3 (da) * 1997-07-29 2003-01-27 Upjohn Co Selvemulgerende formulering indeholdende sure lipofile forbindelser
PT999826E (pt) * 1997-07-29 2004-09-30 Upjohn Co Formulacao auto-emulsionante para compostos lipofilos
JP4462760B2 (ja) * 1997-09-11 2010-05-12 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー プロテアーゼインヒビターとして有用な４−ヒドロキシ−２−オキソ−ピラン誘導体の製法
ATE226579T1 (de) 1999-03-18 2002-11-15 Upjohn Co Verbesserte verfahren fur assymmetrische hydrogenation
US6956048B2 (en) * 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
DK1917958T3 (da) 2000-01-19 2012-09-24 Abbott Lab Forbedrede farmaceutiske formuleringer af HIV proteaseinhibitorer
FI113942B (fi) * 2000-08-18 2004-07-15 Control Ox Oy Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
WO2003070726A1 (en) * 2002-02-25 2003-08-28 Kudos Pharmaceuticals Ltd Pyranones useful as atm inhibitors
AU2003215826A1 (en) * 2002-04-01 2003-10-13 Pfizer Inc. Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
RU2234535C2 (ru) * 2002-10-03 2004-08-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Субстрат для определения активности интегразы вируса иммунодефицита человека
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
IL161586A (en) * 2004-04-22 2015-02-26 Rafael Advanced Defense Sys Irreplaceable energetic material and reactive shielding that uses it
CA2583187A1 (en) * 2004-11-08 2006-05-18 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and etravirine
CA2585576A1 (en) * 2004-11-16 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and darunavir
US20060122220A1 (en) * 2004-11-19 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and UK-427,857
US20060128733A1 (en) * 2004-11-19 2006-06-15 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and reverset
CA2585663A1 (en) * 2004-12-01 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and sch-417690
US20060160859A1 (en) * 2004-12-01 2006-07-20 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and GW873140
WO2006060159A1 (en) * 2004-12-01 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and gw695634
US8598364B2 (en) 2007-03-12 2013-12-03 Nektar Therapeutics Oligomer-protease inhibitor conjugates
US20090062346A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched tipranavir
WO2009042093A1 (en) * 2007-09-25 2009-04-02 Merck & Co., Inc. Hiv protease inhibitors
KR101076680B1 (ko) * 2007-11-01 2011-10-26 한미홀딩스 주식회사 (6ｒ)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체
EP2262498A2 (en) * 2008-03-10 2010-12-22 Vertex Pharmceuticals Incorporated Pyrimidines and pyridines useful as inhibitors of protein kinases
EP2262538B1 (en) 2008-03-12 2014-12-10 Nektar Therapeutics Oligomer-amino acid conjugate
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG172359A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside phosphoramidates
NZ593647A (en) 2008-12-23 2013-08-30 Gilead Pharmasset Llc Synthesis of purine nucleosides
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CA2762582A1 (en) 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. Hiv protease inhibitors
JP2012530069A (ja) 2009-06-12 2012-11-29 ネクター セラピューティックス プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
AU2010262905B2 (en) 2009-06-17 2015-04-16 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
KR101466245B1 (ko) * 2010-01-15 2014-12-01 한미사이언스 주식회사 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
JP2013527145A (ja) 2010-03-31 2013-06-27 ギリード・ファーマセット・エルエルシー リン含有活性化剤の立体選択的合成
WO2012033815A1 (en) * 2010-09-09 2012-03-15 Rutgers, The State University Of New Jersey Arylpropionyl-alpha-pyrone antibacterial agents
US10800725B2 (en) 2010-09-09 2020-10-13 Richard H. Ebright Arylpropionyl-triketone antibacterial agents
US9133155B2 (en) 2010-09-17 2015-09-15 Rutgers, The State University Of New Jersey Antibacterial agents: high-potency myxopyronin derivatives
WO2012055031A1 (en) 2010-10-28 2012-05-03 Merck Canada Inc. Hiv protease inhibitors
KR20140014110A (ko) 2010-12-16 2014-02-05 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2771332B1 (en) 2011-10-26 2016-06-29 Merck Canada Inc. Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS
WO2013103969A1 (en) 2012-01-05 2013-07-11 Rutgers, The State University Of New Jersey Antibacterial agents: phloroglucinol derivatives
CA2882831A1 (en) * 2012-09-11 2014-03-20 Merck Sharp & Dohme Corp. Hiv protease inhibitors
AU2013340559B2 (en) 2012-10-29 2018-03-15 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
WO2015013835A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors
EP3068782B1 (en) 2013-11-13 2018-05-23 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
ES2741444T3 (es) 2013-11-13 2020-02-11 Vertex Pharma Inhibidores de la replicación de virus de la gripe
US9737545B2 (en) 2013-12-19 2017-08-22 Merck Sharp & Dohme Corp. HIV protease inhibitors
US9834526B2 (en) 2013-12-19 2017-12-05 Merck Sharp & Dohme Corp. HIV protease inhibitors
US9994587B2 (en) 2014-03-06 2018-06-12 Merck Sharp & Dohme Corp. HIV protease inhibitors
WO2015138220A1 (en) 2014-03-10 2015-09-17 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors
EP3212196A4 (en) 2014-10-29 2018-07-11 Wisconsin Alumni Research Foundation Boronic acid inhibitors of hiv protease
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
WO2017100645A2 (en) 2015-12-10 2017-06-15 Rutgers, The State University Of New Jersey Inhibitors of bacterial rna polymerase: arylpropanoyl, arylpropenoyl, and arylcyclopropanecarboxyl phloroglucinols
WO2017156458A1 (en) 2016-03-11 2017-09-14 University Of South Florida Beta-lactamase inhibitors, formulations, and uses thereof
US11993590B2 (en) * 2016-12-04 2024-05-28 712 North Inc. Pyranone compounds useful to modulate OMA1 protease
WO2019160875A1 (en) 2018-02-13 2019-08-22 Rutgers, The State University Of New Jersey Antibacterial agents: soluble salts and aqueous formulations of pyronins
EP3752143B1 (en) 2018-02-13 2025-04-09 Rutgers, The State University of New Jersey Antibacterial agents: o-alkyl-deuterated pyronins
WO2019173507A1 (en) 2018-03-06 2019-09-12 Rutgers, The State University Of New Jersey Antibacterial agents : arylalkylcarboxamido phloroglucinols
CN110551090B (zh) * 2019-10-21 2021-06-18 扬州工业职业技术学院 一种超声波提取中药狗脊中抗肿瘤活性成分的方法
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
AU2023395972A1 (en) * 2022-12-16 2025-07-03 Tenvie Therapeutics, Inc. Compounds, compositions, and methods
CN116730993A (zh) * 2023-04-25 2023-09-12 浙江科技学院 一种替拉那韦中间体及替拉那韦的制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB193507A (en) 1921-11-25 1923-02-26 English Electric Co Ltd Improvements in and connected with hydraulic impulse turbines
NL80964C (enExample) * 1952-03-08
BE519956A (enExample) * 1952-05-16
US2723277A (en) * 1952-08-26 1955-11-08 Hoffmann La Roche Malonic acid derivatives and process for the manufacture thereof
US2872457A (en) * 1956-04-19 1959-02-03 Wisconsin Alumni Res Found Process for the preparation of 4-hydroxycoumarin derivatives
GB836740A (en) * 1956-04-25 1960-06-09 Bayer Ag Coumarin derivatives and their production
FR1276654A (fr) * 1958-10-01 1961-11-24 Nouveaux dérivés de l'hydroxy-4-alpha-2-pyrone
FR1463767A (fr) * 1963-04-03 1966-07-22 Clin Byla Ets Dérivés de la coumarine et leur préparation
BE674997A (enExample) * 1965-01-13 1966-07-12
FR1559595A (enExample) * 1966-12-13 1969-03-14
US3489774A (en) * 1967-04-24 1970-01-13 Dow Chemical Co 3-(beta-aryl-beta-(arylthio) (or arylseleno) propionyl)-coumarin products
US3493586A (en) * 1969-01-23 1970-02-03 Dow Chemical Co 3-(beta-aryl-beta-(arylthio) (or arylseleno)-propionyl)pyrone products
JPS4823942B1 (enExample) * 1969-02-14 1973-07-17
US3764693A (en) * 1969-11-21 1973-10-09 Lipha A rodenticidal compositions containing 4-hydroxy coumarins
US3835161A (en) * 1972-10-24 1974-09-10 Realisations Scient S E Res C 3-substituted-4-hydroxy-coumarins
US3931235A (en) * 1972-12-18 1976-01-06 The Dow Chemical Company Process for preparing sulfur-containing hydroxy pyrones
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
CA1171424A (en) * 1981-06-17 1984-07-24 Alvin K. Willard ( )-(4r, 6s) - (e)-6-[2-(4'fluro-3,3', 5-trimethyl- [l,l'-biphenyl]-2-yl)ethenyl]-3,4,5,6- tetrahydro-4-hydroxy-2h-pyran-2-one
JPS634652A (ja) * 1986-06-25 1988-01-09 Hitachi Ltd 半導体装置
WO1988004652A1 (fr) 1986-12-17 1988-06-30 Nippon Soda Co., Ltd. Composes heterocycliques possedant un squelette triketo
US4900754A (en) * 1987-12-21 1990-02-13 Rorer Pharmaceutical Corp. HMG-COA reductase inhibitors
JPH03503635A (ja) * 1988-03-01 1991-08-15 ジ・アップジョン・カンパニー ヒトにおいて逆転写酵素を抑制するクマリン類
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
AU6518890A (en) * 1989-09-26 1991-04-28 Regents Of The University Of California, The 6-amino-1,2-benzopyrones useful for treatment of viral diseases
CA2066644A1 (en) * 1989-10-27 1991-04-28 Robert L. Heinrikson Method for treating hiv and other retroviruses and compounds useful therefor
JPH03227923A (ja) 1990-01-30 1991-10-08 Sawai Seiyaku Kk ひと免疫不全ウイルス疾患処置剤
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
AU8448491A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds and antihypertensive compounds
AU8612491A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds
DE69128481T2 (de) * 1990-09-07 1998-04-09 Schering Corp Antivirale und antihypertensive verbindungen
US5484951A (en) * 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
AU1748792A (en) * 1991-04-04 1992-11-02 Upjohn Company, The Phosphorus containing compounds as inhibitors of retroviruses
RU2131420C1 (ru) * 1991-10-11 1999-06-10 Дзе Дюпон Мерк Фармасьютикал Компани Циклические мочевины, способ ингибирования роста ретровирусов и фармацевтическая композиция
EP0609211A4 (en) * 1991-10-22 1995-02-01 Octamer Inc NITROUS AROMATIC COMPOUNDS THAT BIND ADENOSINE DIPHOSPHORIBOSIS POLYMERASE AS EFFECTIVE ANTI-TUMOR AND ANTI-RETROVIRUS AGENTS.
DE4308451A1 (de) * 1992-09-10 1994-04-14 Bayer Ag 3-Aryl-pyron-Derivate
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
NZ285510A (en) 1998-03-25
LU91220I2 (fr) 2006-04-10
DE122006000014I1 (de) 2006-11-16
PE23196A1 (es) 1996-06-07
FR05C0047I2 (enExample) 2007-10-19
ATE236894T1 (de) 2003-04-15
PL317061A1 (en) 1997-03-03
IL129871A (en) 2003-11-23
HK1066796A1 (zh) 2005-04-01
NO2006003I2 (no) 2008-10-20
FI964441A0 (fi) 1996-11-05
CZ317296A3 (en) 1997-04-16
NO964676D0 (no) 1996-11-05
AU2462695A (en) 1995-11-29
CN1329378C (zh) 2007-08-01
SK284407B6 (sk) 2005-03-04
CA2187523A1 (en) 1995-11-16
NO964676L (no) 1997-01-06
NL300216I2 (nl) 2006-06-01
NO315799B1 (no) 2003-10-27
AU701965B2 (en) 1999-02-11
HUT77601A (hu) 1998-06-29
AU2368699A (en) 1999-06-03
HU228057B1 (en) 2012-09-28
AU718117B2 (en) 2000-04-06
JP3883206B2 (ja) 2007-02-21
DE122006000014I2 (de) 2007-03-29
SK138496A3 (en) 1997-06-04
WO1995030670A3 (en) 1996-04-25
CA2187523C (en) 2006-11-21
HU9603074D0 (en) 1997-01-28
IL113567A (en) 2003-05-29
BR9507615A (pt) 1997-09-09
EP0758327A1 (en) 1997-02-19
US6169181B1 (en) 2001-01-02
NO2006003I1 (no) 2006-03-13
EP0758327B1 (en) 2003-04-09
CA2560489C (en) 2010-01-12
PT758327E (pt) 2003-08-29
FR05C0047I1 (enExample) 2006-03-10
HK1084667A1 (en) 2006-08-04
IL129871A0 (en) 2000-02-29
DE69530294T2 (de) 2003-12-24
KR970702858A (ko) 1997-06-10
KR100445929B1 (ko) 2005-09-30
MY127701A (en) 2006-12-29
CA2560489A1 (en) 1995-11-16
TW504507B (en) 2002-10-01
RU2139284C1 (ru) 1999-10-10
DE69530294D1 (de) 2003-05-15
CZ296515B6 (cs) 2006-04-12
NL300216I1 (nl) 2006-04-03
US5852195A (en) 1998-12-22
CN1539825A (zh) 2004-10-27
CN1150424A (zh) 1997-05-21
SI0758327T1 (en) 2003-08-31
MX9605391A (es) 1997-12-31
DK0758327T3 (da) 2003-07-28
WO1995030670A2 (en) 1995-11-16
JPH09512821A (ja) 1997-12-22
FI117387B (fi) 2006-09-29
MY149862A (en) 2013-10-31
PL190540B1 (pl) 2005-12-30
CN1154642C (zh) 2004-06-23
ES2192201T3 (es) 2003-10-01
FI964441L (fi) 1996-11-05

Similar Documents

Publication Publication Date Title
CO4810313A1 (es) Compuestos utiles para tratar infecciones por retrovirus
DK0533058T3 (da) Imidazo-kondenserede iso- og heterocykler som angiotensin-II-antagonister
ATE219938T1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
FI812995L (fi) Gummielastiska etyleniskt omaettade polyuretaner och dessa innehaollande genom straolning polymeriserbar blandning
ATE232204T1 (de) Neue sulfonamide
KR880007471A (ko) 살균제 피리딜 이미데이트와 이를 이용한 살균제 조성물 및 억제방법
DE69117093D1 (de) Biegsame schmierende organische Beschichtungen
SE8101482L (sv) Sammansatt remskiva
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
IT1311922B1 (it) Composti farmaceutici.
DE69314277D1 (de) Ölbeständige Polysiloxan-Kautschuk-Zusammensetzung
FI93391B (fi) Menetelmä voimakkaan hankauskulutuksen alaisten laitteistoyksityiskohtien ja komponenttien vahvistamiseksi tai korjaamiseksi
ATE355048T1 (de) Kosmetische zusammensetzung
ATE109173T1 (de) Isocyanurathaltige organosiliciumverbindungen.
DE69724646D1 (de) 16-ene-vitamin d derivate
ES2157887T3 (es) Compuestos heterociclicos que contienen azufre.
TR200001290T2 (tr) Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler.
AR023300A1 (es) COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR.
ATE136307T1 (de) Trazodone alkyl derivate mit zns wirkung
DE58903821D1 (de) Verwendung von addukten von 1,2-butylenoxid an aminen als schmierstoffe und schmierstoffe, diese addukte enthaltend.
ATE158566T1 (de) Verwendung von fluorierten kohlenwasserstoffderivaten in kosmetischen zusammensetzungen, fluorierte kohlenwasserstoffderivate, und sie enthaltende kosmetische zubereitungen
SE7902906L (sv) Medel for forhindring av inkrustbildning
NO841451L (no) Fremgangsmaate ved fremstilling av disubstituerte polymetyleniminer
DE69117376D1 (de) Kohlenwasserstoffölzusammensetzungen
ES2046496T3 (es) Procedimiento para la preparacion de agentes de hidroxialquilacion, los nuevos agentes asi obtenidos y su empleo.